MedTrace Logo

Trial to See if Topical Pennsaid for Knee Pain Affects Coagulation Values in Patients Who Are Also Taking Anticoagulants

NCT01511939 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2014-06-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if using a topical nonsteroidal antiinflammatory drug (Pennsaid) to treat osteoarthritis knee pain will affect coagulation values in patients who are also taking anticoagulant or antithrombotic medications.

Conditions

  • Osteoarthritis of the Knee
  • Coagulopathy

Interventions

DRUG

Pennsaid

Administered 10 drops x 4 until 40 drops applied topically to index knee (and also non-index knee if osteoarthritis pain is present bilaterally) 4 times a day for a 4 week active treatment period.

Sponsors & Collaborators

  • Medtronic - MITG

    collaborator INDUSTRY

  • Arthritis Treatment Center, Maryland

    collaborator OTHER

  • Nathan Wei, MD, FACP, FACR:

    lead OTHER

Principal Investigators

  • Nathan Wei, MD,FACP,FACR · Arthritis Treatment Center, Frederick, Maryland, United States, 21702

Study Design

Allocation
NON_RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2013-05-31
Completion
2013-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01511939 on ClinicalTrials.gov